s6y
Company name or ticker
Search
Amylyx Pharmaceuticals, Inc.
4
Klee Justin B.: Statement of changes in beneficial ownership of securities
Filed
Monday, September 14, 2026
Period
Sep 10, 2026
Accession number
0001193125-26-390506
Documents
4
4
On sec.gov
Filing index
All files
Complete submission text
SGML header